Results 71 to 80 of about 1,346,163 (252)

Clinicopathologic Analysis of Sarcomas in the Oral and Maxillofacial Region: A Systematic Review

open access: yesOral Diseases, EarlyView.
ABSTRACT Objective This study aimed to systematically review primary sarcomas in the oral and maxillofacial region, focusing on patient demographics and sarcoma‐specific characteristics, including clinical presentation, histopathology, treatment approaches, outcomes, and survival rates.
Iara Vieira Ferreira   +7 more
wiley   +1 more source

Primary Mucoepidermoid Carcinoma of the Thyroid: A Report of a Rare Case with Bone Metastasis and Review of the Literature

open access: yesCase Reports in Oncology, 2019
Mucoepidermoid carcinomas (MECs) are generally found in salivary gland, but they have also been mentioned in other organs such as the larynx, esophagus, breast.
Q. Le, D. Q. Ngo, Q. Ngo
semanticscholar   +1 more source

Mucoepidermoid Carcinoma of Palate-Diagnostic Challenges

open access: yesJournal of Indian Academy of Oral Medicine and Radiology, 2004
A 32 years old male reported with pain and swelling in left maxillary region of face since 2 months and painless palatal swelling on left side since 1 year Radiographic features were mimicking a fibro osseous lesion, while CT scan was suggestive of ...
R S Sathawane, R N Mody, A R Parate
doaj  

Evaluation of Cystic Salivary Gland Lesions by Fine-Needle Aspiration: An Analysis of 21 Cases [PDF]

open access: yes, 2005
Objective: To analyze the potential sources of diagnostic errors and overall accuracy rate of the fine needle aspiration biopsy (FNAB) diagnosis of cystic salivary gland neoplasms.
Edwards, Paul C., Wasserman, Patricia
core  

Primary intraosseous carcinoma of mandible: an update on review of literature with a case report [PDF]

open access: yes, 2010
Primary intraosseous carcinoma (PIOC) is a rare malignant neoplasm of the jaws which is locally aggressive with quite poor prognosis. Overall and disease free survival is poor with almost 50% patients failing within first 2 years of follow up and ...
Jindal, Sanjeev Kumar   +3 more
core   +1 more source

Late Toxicity and Long‐Term Quality of Life in Survivors of Cancer of the Major Salivary Glands More Than 5 Years After Diagnosis: A Multi‐National Study

open access: yesHead &Neck, Volume 48, Issue 1, Page 13-25, January 2026.
ABSTRACT Background Because salivary gland cancers (SGC) are rare and include different tumor subtypes, data on their long‐term quality of life and late toxicities are sparse. Methods Multi‐national study including SGC survivors more than 5 years after diagnosis.
Susanne Singer   +26 more
wiley   +1 more source

Central mucoepidermoid carcinoma: Case report with review of literature

open access: yesNational Journal of Maxillofacial Surgery, 2019
Occurrence of central mucoepidermoid carcinoma within the jaw bones from aberrant salivary tissues is extremely rare and accounts for 2%–4% of all central mucoepidermoid carcinoma. Mandible is more commonly affected than maxilla in a ratio of 2:1.
Harmurti Singh   +4 more
semanticscholar   +1 more source

Mucoepidermoid carcinoma arising in Warthin􀆳s tumor of the upper lip: a case report and review

open access: yes口腔疾病防治, 2019
Objective To provide a reference for the diagnosis and treatment of mucoepidermoid carcinoma arising in Warthin􀆳s tumor of the lip by investigating the diagnosis, treatment and prognosis of the disease.
ZHANG Ning   +7 more
doaj   +1 more source

High-grade mucoepidermoid carcinoma in thyroglossal cyst: Post-surgical histological surprise and dilemmas

open access: yesAsian Journal of Medical Sciences, 2021
Occurrence of malignancy in the TG cyst has been rarely reported, though rare, and papillary carcinoma predominates the common type but squamous cell carcinomas, anaplastic carcinoma, and medullary have been reported rarely. Mucoepidermoid carcinomas are
Ravindran Chirukandath   +5 more
doaj   +1 more source

Efficacy of Almonertinib Versus Osimertinib as the First‐Line Treatment for Non‐Small Cell Lung Cancer With EGFR L858R Mutation and Prognostic Analysis: A Retrospective Comparative Cohort Study

open access: yesCancer Medicine, Volume 14, Issue 23, December 2025.
ABSTRACT Objectives Epidermal growth factor receptor (EGFR)–specific tyrosine kinase inhibitors show less efficacy against the EGFR L858R mutation than EGFR 19del, but no current head‐to‐head clinical trials have been performed comparing the efficacy of almonertinib and osimertinib.
Xiujing Yao   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy